# K041446: Nasalcease

- Pathway: 510(k) (Traditional)
- Applicant: Les Laboratorires Brothier, S.A.
- Decided: Jul 1, 2004 after 30 days
- Product code: EMX (Balloon, Epistaxis)
- Device class: 1
- Regulation: 21 CFR 874.4100
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K821150 (1982). 6 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K984069: Entaxis Nasal Packing, Les Laboratorires Brothier, S.A. (1999). Our reading of the summary gave K985069, which is not a number in FDA’s lists. Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “ENTaxis”.

## Most influential descendants
- K102742: Nasal Cease (2011), 1 descendant of its own
- K183622: NasalCEASE and BleedCEASE (2019), 0 descendants of its own

## Indications for use
This device has the following intended use. 1. NasaICEASETM is intended to be inserted into the anterior nasal cavity to stop minor nosebleeds. It is intended to be marketed and sold as an Over-The-Counter device.

Source page: https://510kreport.com/device/K041446
Methodology: https://510kreport.com/methodology